Optiray 350 741 mg/mL (Ioversol INJECTION) 741 mg/mL

Optiray 350 741 mg/mL is a radiopaque contrast agent used for diagnostic imaging procedures. This injection, containing ioversol, aids in enhancing visibility during imaging studies. Ideal for intra-arterial and intravenous use, it is a trusted choice for medical professionals.

Strength

741 mg/mL

Pack Size

20 SYRINGE, PLASTIC in 1 CARTON (0019-1333-77) / 50 mL in 1 SYRINGE, PLASTIC

Manufacturer / TM Owner

Liebel-Flarsheim Company LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Optiray 350 741 mg/mL is primarily used as a contrast medium to improve the visibility of internal structures during imaging procedures. It is commonly administered for diagnostic purposes, such as angiography and computed tomography (CT) scans. The primary keyword, ioversol, refers to the active ingredient in this contrast agent, which helps in highlighting blood vessels and other internal structures. What is Optiray 350 used for? It is typically used to enhance the clarity of images, making it easier for healthcare providers to diagnose and monitor various conditions.

Side Effects

When administered, Optiray 350 741 mg/mL may cause a temporary warming sensation or a metallic taste in the mouth. Some individuals might experience mild discomfort at the injection site. These effects are generally short-lived and subside quickly. It is important to note that individual responses to the contrast agent can vary.

Precautions & Warnings

Optiray 350 741 mg/mL should be used with caution in individuals with a history of allergic reactions to contrast media. It is essential to inform healthcare providers about any existing medical conditions or allergies before administration. Proper handling and storage are crucial to maintain the integrity and effectiveness of the contrast agent.

Avoid Interactions

Optiray 350 741 mg/mL may interact with certain medications or substances. It is advisable to avoid alcohol consumption before and after the procedure, as it can enhance the risk of side effects. Additionally, individuals taking medications that affect kidney function should consult their healthcare provider before using this contrast agent.

Frequently Asked Questions

Optiray 350 is used as a contrast medium to enhance the visibility of internal structures during imaging procedures such as angiography and CT scans.

Optiray 350 is typically administered via intra-arterial or intravenous injection, depending on the specific imaging procedure.

Common side effects may include a temporary warming sensation, metallic taste, or mild discomfort at the injection site.

Individuals with kidney problems should consult their healthcare provider before using Optiray 350, as it may affect kidney function.

Optiray 350 should be used with caution in individuals with a history of allergic reactions to contrast media. Always inform your healthcare provider about any allergies.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.